메뉴 건너뛰기




Volumn 123, Issue 17, 2011, Pages 1891-1899

Novel antiplatelet drug revacept (dimeric glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans

Author keywords

glycoprotein VI; platelet adhesion; platelet aggregation; platelet aggregation inhibitors; stroke

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; COLLAGEN; REVACEPT; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG;

EID: 85027958733     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.980623     Document Type: Article
Times cited : (208)

References (29)
  • 1
    • 0036851876 scopus 로고    scopus 로고
    • Platelets in atherothrombosis
    • DOI 10.1038/nm1102-1227
    • Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8:1227-1234. (Pubitemid 35373553)
    • (2002) Nature Medicine , vol.8 , Issue.11 , pp. 1227-1234
    • Ruggeri, Z.M.1
  • 2
    • 0037118664 scopus 로고    scopus 로고
    • Platelet glycoprotein IIb/IIIa inhibitors: Recognition of a two-edged sword?
    • DOI 10.1161/01.CIR.0000019581.22812.B2
    • Quinn MJ, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa inhibitors: recognition of a two-edged sword? Circulation. 2002;106:379-385. (Pubitemid 34778965)
    • (2002) Circulation , vol.106 , Issue.3 , pp. 379-385
    • Quinn, M.J.1    Plow, E.F.2    Topol, E.J.3
  • 3
    • 74549203360 scopus 로고    scopus 로고
    • Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndrome
    • Van de Werf F. Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndrome. Circulation. 2010;121:5-7.
    • (2010) Circulation , vol.121 , pp. 5-7
    • Van De Werf, F.1
  • 7
    • 0038494921 scopus 로고    scopus 로고
    • Platelet-collagen interaction: Is GPVI the central receptor?
    • DOI 10.1182/blood-2002-12-3882
    • Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood. 2003;102:449-461. (Pubitemid 36841960)
    • (2003) Blood , vol.102 , Issue.2 , pp. 449-461
    • Nieswandt, B.1    Watson, S.P.2
  • 11
    • 13544270777 scopus 로고    scopus 로고
    • Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice
    • DOI 10.1182/blood-2004-06-2391
    • Gruner S, Prostredna M, Koch M, Miura Y, Schulte V, Jung SM, Moroi M, Nieswandt B. Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice. Blood. 2005;105: 1492-1499. (Pubitemid 40223665)
    • (2005) Blood , vol.105 , Issue.4 , pp. 1492-1499
    • Gruner, S.1    Prostredna, M.2    Koch, M.3    Miura, Y.4    Schulte, V.5    Jung, S.M.6    Moroi, M.7    Nieswandt, B.8
  • 13
    • 4944261759 scopus 로고    scopus 로고
    • Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy
    • DOI 10.1161/01.CIR.0000137972.74120.12
    • Kastrati A, von BN, Joost A, Pogatsa-Murray G, Gorchakova O, Schomig A. Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy. Circulation. 2004; 110:1916-1919. (Pubitemid 39331901)
    • (2004) Circulation , vol.110 , Issue.14 , pp. 1916-1919
    • Kastrati, A.1    Von Beckerath, N.2    Joost, A.3    Pogatsa-Murray, G.4    Gorchakova, O.5    Schomig, A.6
  • 15
    • 38949179203 scopus 로고    scopus 로고
    • Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions. Appropriateness of Including Bleeding as a Component of a Quadruple End Point
    • DOI 10.1016/j.jacc.2007.10.040, PII S073510970703745X
    • Ndrepepa G, Berger PB, Mehilli J, Seyfarth M, Neumann FJ, Schomig A, Kastrati A. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol. 2008;51: 690-697. (Pubitemid 351221218)
    • (2008) Journal of the American College of Cardiology , vol.51 , Issue.7 , pp. 690-697
    • Ndrepepa, G.1    Berger, P.B.2    Mehilli, J.3    Seyfarth, M.4    Neumann, F.-J.5    Schomig, A.6    Kastrati, A.7
  • 17
    • 77951537668 scopus 로고    scopus 로고
    • Platelet glycoprotein VI (GPVI) for early identification of acute coronary syndrome in patients with chest pain
    • Bigalke B, Haap M, Stellos K, Geisler T, Seizer P, Kremmer E, Overkamp D, Gawaz M. Platelet glycoprotein VI (GPVI) for early identification of acute coronary syndrome in patients with chest pain. Thromb Res. 2010;125:e184-e189.
    • (2010) Thromb Res , vol.125
    • Bigalke, B.1    Haap, M.2    Stellos, K.3    Geisler, T.4    Seizer, P.5    Kremmer, E.6    Overkamp, D.7    Gawaz, M.8
  • 20
    • 67349237179 scopus 로고    scopus 로고
    • Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS)
    • Bigalke B, Stellos K, Weig HJ, Geisler T, Seizer P, Kremmer E, Potz O, Joos T, May AE, Lindemann S, Gawaz M. Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS). Basic Res Cardiol. 2009;104:352-357.
    • (2009) Basic Res Cardiol , vol.104 , pp. 352-357
    • Bigalke, B.1    Stellos, K.2    Weig, H.J.3    Geisler, T.4    Seizer, P.5    Kremmer, E.6    Potz, O.7    Joos, T.8    May, A.E.9    Lindemann, S.10    Gawaz, M.11
  • 23
    • 4444244926 scopus 로고    scopus 로고
    • Anti-GPVI-associated ITP: An acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRγ-chain complex from the human platelet surface
    • DOI 10.1182/blood-2004-03-0896
    • Boylan B, Chen H, Rathore V, Paddock C, Salacz M, Friedman KD, Curtis BR, Stapleton M, Newman DK, Kahn ML, Newman PJ. Anti- GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface. Blood. 2004;104: 1350-1355. (Pubitemid 39166510)
    • (2004) Blood , vol.104 , Issue.5 , pp. 1350-1355
    • Boylan, B.1    Chen, H.2    Rathore, V.3    Paddock, C.4    Salacz, M.5    Friedman, K.D.6    Curtis, B.R.7    Stapleton, M.8    Newman, D.K.9    Kahn, M.L.10    Newman, P.J.11
  • 24
    • 0024426540 scopus 로고
    • A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion
    • Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest. 1989;84:1440-1445. (Pubitemid 19272230)
    • (1989) Journal of Clinical Investigation , vol.84 , Issue.5 , pp. 1440-1445
    • Moroi, M.1    Jung, S.M.2    Okuma, M.3    Shinmyozu, K.4
  • 25
    • 43749099001 scopus 로고    scopus 로고
    • Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression
    • DOI 10.1111/j.1538-7836.2008.02976.x
    • Ohlmann P, Hechler B, Ravanat C, Loyau S, Herrenschmidt N, Wanert F, Jandrot-Perrus M, Gachet C. Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression. J Thromb Haemost. 2008;6: 1003-1011. (Pubitemid 351689923)
    • (2008) Journal of Thrombosis and Haemostasis , vol.6 , Issue.6 , pp. 1003-1011
    • Ohlmann, P.1    Hechler, B.2    Ravanat, C.3    Loyau, S.4    Herrenschmidt, N.5    Wanert, F.6    Jandrot-Perrus, M.7    Gachet, C.8
  • 27


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.